iSpecimen (NASDAQ:ISPC – Get Free Report) will issue its quarterly earnings data before the market opens on Tuesday, August 6th. Parties interested in listening to the company’s conference call can do so using this link.
iSpecimen (NASDAQ:ISPC – Get Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.32) EPS for the quarter. iSpecimen had a negative net margin of 124.84% and a negative return on equity of 105.25%. The company had revenue of $2.29 million for the quarter.
iSpecimen Price Performance
Shares of NASDAQ ISPC traded down $0.01 during mid-day trading on Tuesday, reaching $0.28. 562,399 shares of the company traded hands, compared to its average volume of 2,285,401. iSpecimen has a fifty-two week low of $0.20 and a fifty-two week high of $1.73. The firm has a market cap of $3.60 million, a PE ratio of -0.22 and a beta of 1.60. The stock has a fifty day simple moving average of $0.33 and a 200-day simple moving average of $0.35.
About iSpecimen
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
See Also
- Five stocks we like better than iSpecimen
- Ride Out The Recession With These Dividend KingsĀ
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- High Flyers: 3 Natural Gas Stocks for March 2022
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What is a Bond Market Holiday? How to Invest and Trade
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.